Michela Cimberle

The introduction of the first disease-modifying therapies fundamentally transformed the management of geographic atrophy and brought new changes and challenges in clinical practice, workflow and capacity.The FDA approved complement inhibitors Syfovre (pegcetacoplan injection, Apellis) and Izervay (avacincaptad pegol intravitreal solution, Astellas) in 2023, and since then, the approach to

Using sulcus lenses in cases of intraoperative complications.Inspecting and monitoring the lens during implantation to recognize any defects.

In recent decades, the microbiome has emerged as a dynamic ecosystem, an “invisible organ” that plays a crucial role in systemic health and, more recently, in ophthalmology.When naturally balanced, this complex community of microorganisms and genetic material can fulfill multiple functions that are essential to a person’s well-being. Recent research has shown that when this

Dementia is a highly prevalent condition, affecting 57 million people worldwide, with nearly 10 million new cases each year, according to a recent WHO report.In 2020, the Lancet Commission on dementia identified 12 modifiable risk factors: less education, hearing loss, hypertension, smoking, obesity, depression, physical inactivity, diabetes, excessive alcohol consumption, traumatic brain injury,

PARIS — A retrospective analysis of a large cohort of patients with diabetic macular edema showed high prevalence of bilateral disease at first visit, high treatment burden and high frequency of fellow eye progression in unilateral cases. “The purpose of this study was to understand where our patients are right now with DME and what can we learn about them and how they’re being managed, so we can

AI paired with the technological advances of automated and robotic fundus cameras will be a catalyst for change. These technologies hold the potential to take specialist-level eye screening into primary care, pharmacies and preclinical spaces, reaching out to people in low-resource settings and underserved areas, to rapidly detect and manage a wide range of ocular and systemic conditions. I am a

With AI moving at a fast pace, oculomics — the study of the eye as a window to systemic health — is expanding its potential and gaining increasing attention. The past few years have seen an abundance of studies and initiatives aimed at creating strategic partnerships for collaborative projects in this area. Oculomics-based AI systems promise to become a transformative tool for risk stratification

PARIS — The Prima photovoltaic retinal stimulation microchip shows promise for restoring central vision in patients with foveal geographic atrophy, according to a speaker.

In the fight against vision loss and blindness, eye banks play a crucial role.As intermediaries between donors and recipients, eye banks manage multiple tasks, support families throughout the donation process, and test, store and provide safe, high-quality tissue to surgeons. They are active in organizing awareness campaigns and educating the public about the importance of eye donation. Some are

Driven by climate change, population mobility and global trade, mosquito-borne diseases are extending beyond tropical and subtropical areas.Outbreaks of dengue, chikungunya and Zika, carried by Aedes mosquitoes, are increasingly occurring in Europe and North America. Aedes mosquitoes, including Aedes aegypti and Aedes albopictus (Asian tiger mosquitoes), are known vectors of several diseases.